Wissenschaftliche Publikationen Suche Suche Autor/in Forschungsgruppe Veröffentlichungsdatum Suchen Sortieren nach RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Reihenfolge AufsteigendAbsteigend Bunse, Mario Dr. (1) Janz, Martin Dr. (6) Kammertöns, Thomas Dr. (1) Leisegang, Matthias Prof. Dr. rer. nat. (1) Lusatis, Simone (1) Mathas, Stephan Dr. (7) Pezzutto, Antonio Prof. Dr. (1) Selbach, Matthias Prof. Dr. (3) Uckert, Wolfgang Prof. Dr. (3) Willimsky, Gerald Dr. (1) Wollert-Wulf, Brigitte (2) (-) Blankenstein, Thomas Prof. Dr. (12) (-) Daniel, Peter Prof. Dr. (1) (-) Biologie maligner Lymphome (1) (-) Molekulare Immunologie und Gentherapie (12) Translationale Onkologie solider Tumore (1) 1992 (4) 1993 (7) 1994 (5) 1995 (8) (-) 1996 (6) 1997 (9) 1998 (9) 1999 (2) 2000 (8) 2001 (5) 2002 (5) 2003 (9) 2004 (8) 2005 (10) (-) 2006 (2) (-) 2007 (5) 2008 (5) 2009 (2) 2010 (7) 2011 (5) 2012 (6) 2013 (11) 2014 (4) 2015 (4) 2016 (4) 2017 (6) 2018 (4) 2019 (6) 2021 (4) 2022 (6) 2023 (5) 2024 (1) 13 Ergebnisse: Active Filter: Blankenstein, Thomas Prof. Dr.Daniel, Peter Prof. Dr.Biologie maligner LymphomeMolekulare Immunologie und Gentherapie 199620062007 Sortieren: Treffgenauigkeit Neueste nach älteste Älteste nach neueste 01. Dezember 2007 / Immunol Rev The adaptive immune response to sporadic cancer G. Willimsky T. Blankenstein 01. August 2007 / Semin Cancer Biol Do autochthonous tumors interfere with effector T cell responses? T. Blankenstein 01. Oktober 2007 / Gene Ther In vivo splenic CD11c cells downregulate CD4 T-cell response thereby decreasing systemic immunity to gene-modified tumour cell vaccine S. Cayeux B. Bukarica C. Buschow J. Charo M. Bunse B. Doerken T. Blankenstein 15. Oktober 2007 / J Immunol Dual T cell receptor expressing CD8+ T cells with tumor- and self-specificity can inhibit tumor growth without causing severe autoimmunity M. Weinhold D. Sommermeyer W. Uckert T. Blankenstein 01. November 2006 / Eur J Immunol Designer T cells by T cell receptor replacement D. Sommermeyer J. Neudorfer M. Weinhold M. Leisegang B. Engels E. Noessner M.H. Heemskerk J. Charo D.J. Schendel T. Blankenstein H. Bernhard W. Uckert 01. Januar 2007 / J Immunother T cell homing to tumors detected by 3D-coordinated positron emission tomography and magnetic resonance imaging R. Agger M.S. Petersen C.C. Petersen S.B. Hansen H. Stodkilde-Jorgensen U. Skands T. Blankenstein T.E. Andersen E.F. Hulgaard J.T. Jorgensen J. Marqversen H.J. Gundersen M.E. Hokland 01. April 2006 / Cell Death Differ Loss of the tissue-specific proapoptotic BH3-only protein Nbk/Bik is a unifying feature of renal cell carcinoma I. Sturm C. Stephan B. Gillissen R. Siebert M. Janz S. Radetzki K. Jung S. Loening B. Doerken P.T. Daniel 01. Januar 1996 / Gene Ther Cancer vaccines in gene therapy T. Blankenstein Z. Qin 01. Januar 1996 / Hum Gene Ther Coexpression of interleukin-4 and B7.1 in murine tumor cells leads to improved tumor rejection and vaccine effect compared to single gene transfectants and a classical adjuvant S. Cayeux C. Beck B. Doerken T. Blankenstein 01. Januar 1996 / Curr Top Microbiol Immunol The influence of local cytokines on tumor metastasis: using cytokine gene transfected tumor cells as experimental models Z. Qin T. Blankenstein Seitennummerierung Aktuelle Seite 1 Seite 2 Nächste Seite Next › Letzte Seite Last »
01. Dezember 2007 / Immunol Rev The adaptive immune response to sporadic cancer G. Willimsky T. Blankenstein
01. August 2007 / Semin Cancer Biol Do autochthonous tumors interfere with effector T cell responses? T. Blankenstein
01. Oktober 2007 / Gene Ther In vivo splenic CD11c cells downregulate CD4 T-cell response thereby decreasing systemic immunity to gene-modified tumour cell vaccine S. Cayeux B. Bukarica C. Buschow J. Charo M. Bunse B. Doerken T. Blankenstein
15. Oktober 2007 / J Immunol Dual T cell receptor expressing CD8+ T cells with tumor- and self-specificity can inhibit tumor growth without causing severe autoimmunity M. Weinhold D. Sommermeyer W. Uckert T. Blankenstein
01. November 2006 / Eur J Immunol Designer T cells by T cell receptor replacement D. Sommermeyer J. Neudorfer M. Weinhold M. Leisegang B. Engels E. Noessner M.H. Heemskerk J. Charo D.J. Schendel T. Blankenstein H. Bernhard W. Uckert
01. Januar 2007 / J Immunother T cell homing to tumors detected by 3D-coordinated positron emission tomography and magnetic resonance imaging R. Agger M.S. Petersen C.C. Petersen S.B. Hansen H. Stodkilde-Jorgensen U. Skands T. Blankenstein T.E. Andersen E.F. Hulgaard J.T. Jorgensen J. Marqversen H.J. Gundersen M.E. Hokland
01. April 2006 / Cell Death Differ Loss of the tissue-specific proapoptotic BH3-only protein Nbk/Bik is a unifying feature of renal cell carcinoma I. Sturm C. Stephan B. Gillissen R. Siebert M. Janz S. Radetzki K. Jung S. Loening B. Doerken P.T. Daniel
01. Januar 1996 / Hum Gene Ther Coexpression of interleukin-4 and B7.1 in murine tumor cells leads to improved tumor rejection and vaccine effect compared to single gene transfectants and a classical adjuvant S. Cayeux C. Beck B. Doerken T. Blankenstein
01. Januar 1996 / Curr Top Microbiol Immunol The influence of local cytokines on tumor metastasis: using cytokine gene transfected tumor cells as experimental models Z. Qin T. Blankenstein